SUMMARY It has been suggested that Coxsackie B virus infections may play a part in causing or triggering myocardial infarction. This study was designed to compare the incidence of such infections in Coronary Care Unit patients and normal controls. The choice of a suitable criterion for diagnosis of Coxsackie infection is discussed fully.
Two hundred and fifty admissions to a Coronary Care Unit and 100 control subjects had a serum sample tested by microneutralisation for Coxsackie B antibodies. The incidence of infection among 130 patients diagnosed as acute myocardial infarction was 5% compared with 4% in the control group.
In a subgroup classified as non-transmural myocardial infarction, the incidence of infection was 14%. The sex ratio of this group differed from the myocardial infarction group as a whole suggesting that the non-transmural group may not have been homogeneous. Normal coronary arteriograms were subsequently found in three patients who were diagnosed as non-transmural myocardial infarction but who had serological evidence of recent Coxsackie infection.
This study does not demonstrate an association between Coxsackie infection and myocardial infarction as a whole and does not support the view that Coxsackie infection causes or provokes myocardial infarction. It does, however, suggest that myocarditis may simulate non-transmural infarction. During the period of study blood samples were also drawn from a control group of outpatients with hypertension, peptic ulcer, chronic stable angina and osteoarthritis. Sera were separated and stored at -20°C. Before use they were heated at 56°C for 30 658
Coxsackie B virus infection in coronary care unit patients min. Neutralising antibodies to Coxsackie group B viruses types 1-5 were estimated by a microneutralisation test as described by Bell and Grist 1970.6 Sera were tested in serial twofold dilutions against approximately 100 TCD of virus (unit volume 0-025 ml) in microtitre plates. Serum-virus mixtures were incubated for one hour at room temperature before the addition of 0-1 ml of Hela cell suspension (15 000 cells in medium containing 10% fetal calf serum). Parallel plates were set up using serial dilutions of standard antisera to Coxsackie B types 1-5 (Colindale). Plates were incubated at 37°C in a humidified incubator for three days in 5% CO2 in air. The cytopathic effect was read visually, the end point being the last dilution not to show a cytopathic effect.
Three patients were subjected to coronary arteriography as a part of this study (see below). Coronary arteriograms in right and left oblique views with added caudocranial projections were obtained both on cine and cut film at least three months after the acute admission. 3 The remaining 90 patients were classified as "doubtful" and will not be considered further in the context of validation of criteria for diagnosis of recent infection. Serological data from groups 1 and 2 were compared with a view to distinguish recent infection from incidentally raised titres.
Seventy-one patients in group 1 and 22 patients in group 2 had paired samples of serum available. A fourfold rise in titre was found in four patients in group 1 and one patient in group 2 (the latter patient was admitted with acute generalised lymph node enlargement and was subsequently diagnosed as having Hodgkin's disease). A fourfold rise in titre was uncommon in this study even in patients with clinical evidence of a recent Coxsackie infection and was therefore not by itself regarded as a suitably sensitive criterion for the diagnosis of a recent infection. In only five instances was there a raised titre in the second sample following a normal first sample and only two of these cases were in group 1. This confirms that the titres are usually raised by the time of clinical presentation.
A single serotype rise was found to be equally common in both groups 1 and 2 and therefore did not correlate with recent infection as suggested by Nicholls and Thomas.4 We examined also the correlation of the titre height (on presentation) with the clinical diagnosis. The results are shown in the Figure. The incidence of serological evidence of Coxsackie infections in the CCU patients and controls is shown in Table 1 . Of the MI group seven of 130 patients (5%) had evidence of infection compared with four of 100 (4%) of the control group. If the non-transmural MI group is considered separately, the incidence of infection was considerably higher (14%) than in the control group, but the number of patients in this sample (22) is small and thus this difference is not statistically significant. The non-MI chest pain group included six from 120 patients with serological evidence of Coxsackie infection (5%).
There was therefore no increased incidence of Coxsackie infections among MI patients or non-MI chest pain patients. As expected the subgroup of CCU patients with a clinical diagnosis of viral myopericarditis showed an increased incidence of Coxsackie infection-four from 11 patients (36%) (p < 0.05).
All seven of the MI patients with serological evidence of Coxsackie infection had anteriorly sited infarctions (Table 2) , an unexpected finding (p < 0.01) in view of the ratio of anterior to inferior MI in the group as a whole.
Three patients classified as non-transmural myocardial infarction but with serological evidence of recent Coxsackie infection, were subjected to coronary arteriography from 3-8 months after the acute event. All three showed normal arteriograms (no stenosis greater than 20%).
Discussion
Of the 250 admissions to the CCU in this study an initial clinical diagnosis of viral myopericarditis was attached to only 11 patients (4%). Four of these 11 patients (36%) subsequently proved to have serological evidence of Coxsackie infection. The remaining seven patients presumably had infection due either to other viruses (although screening for common respiratory viruses was negative in all cases) or to infection with Coxsackie B virus associated with titres lower than our criterion demanded (three patients in this group had Coxsackie titres of 1/256). Clearly defined Coxsackie illnesses were therefore relatively uncommon in our CCU occurring in only 2% of admissions. It has, however, been suggested by Woods et al,3 that covert Coxsackie infection may cause, provoke or simulate MI in some instances. Their study based on a fourfold rise in neutralisation titre was however uncontrolled. Nicholls and Thomas,4 also in an uncontrolled study, found a fourfold rise in titre in 7/38 MI patients. Our own study however failed to demonstrate an increased incidence of Coxsackie infections in MI patients and is in line with the conclusions of Griffiths et al.5 There was, in addition, no evidence that Coxsackie infection contributes significantly to the problem of non-MI chest pain in the CCU.
Our finding of an excess of anterior MI patients among those with serological evidence of Coxsackie infection supports the observation of Wood et al,9 although Woods et al3 found no significant excess in their 20 patients with transmural MI.
The subgroup classified as non-transmural MI has several interesting features: (i) the sex ratio of 1:1 differs significantly from that of the total MI group, suggesting that this subgroup contains patients with pathology other than coronary artery disease. It is of interest that Pohjola et all' noted a similar difference in sex ratio between transmural and non-transmural infarction in a large study involving 728 MI patients; (ii) three patients from this subgroup, who had evidence of recent Coxsackie infection, were subsequently demonstrated to have normal coronary arteriograms-a finding quite unexpected in nontransmural MI"1; (iii) the incidence of infection in this subgroup was 14% compared with 4% in the control group. Although this difference lacks statistical significance, such significance would be difficult to obtain in the presence of such small numbers satisfying the criteria for infection.
These findings suggest that the group classified as non-transmural MI may have contained patients who, in fact, suffered from viral myocarditis. The electrocardiographic changes of myocarditis are usually most prominent in anterior leads. Of these patients 14% (3/22) had evidence of recent Coxsackie infection using our criteria and none showed significant titres by complement fixation to the following antigens: psittacosis-LGV, Mycoplasma pneumoniae, influenza A and B, adenovirus, parainfluenza, herpes simplex, respiratory syncytial virus, cytomegalovirus, varicella zoster and measles. An agent affecting 19/22 (86%) of patients in this group with findings compatible with acute viral myocarditis has not been defined in this study. A similar situation exists in the group of patients presenting with a clinical picture of acute viral myopericarditis: a minority, 36% (4/11), had evidence of a recent infection with Coxsackie B by our criteria. It is possible that viruses not routinely tested for-for example, Coxsackie A-may play a role in contributing to undiagnosed viral infections in the groups studied.
We have therefore failed to demonstrate an association between Coxsackie infection and MI as a whole but suggest that viral myocarditis may be wrongly diagnosed as non-transmural MI in a number of patients (small in relation to all MI patients).
Further scrutiny of patients diagnosed as nontransmural MI is indicated, for prognostic reasons, to exclude cases of myocarditis (which may explain some cases of "MI" with normal coronary arteriograms). We are currently engaged in an angiographic study designed to investigate this question. The availability of a reliable method of detecting IgM specific for Coxsackie B virus would also help to clarify the situation.
